Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mdevice Co. Ltd. (226590:KRX), powered by AI.
Mdevice Co. Ltd. is currently trading at ₩22,600. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Mdevice Co. Ltd. on Alpha Lenz.
Mdevice Co. Ltd.'s P/E ratio is 22.6.
“Mdevice Co. Ltd. trades at a P/E of 22.6 (fair value) with strong ROE of 29.2%. 3Y revenue CAGR of 112.1% highlights clear growth momentum.”
Ask for details →Mdevice Co. Ltd. is an innovative company specializing in the design, development, and manufacturing of medical devices and healthcare solutions. The primary function of this company is to enhance patient care and medical processes by providing high-quality, reliable medical equipment. Mdevice Co. Ltd. impacts the healthcare industry significantly by producing a variety of products, including diagnostic machines, surgical instruments, and patient monitoring systems. These products serve hospitals, clinics, and healthcare professionals globally, ensuring improved health outcomes and operational efficiency. Mdevice Co. Ltd. plays an essential role in the financial market as a key player in the medical technology sector. The company is recognized for its commitment to research and development, which ensures the continuous advancement of healthcare technologies. Its extensive product portfolio and strategic partnerships with healthcare institutions make it a crucial contributor to advancements in medical care and technology. Additionally, Mdevice Co. Ltd.'s market presence and product innovation support its position as a leader in the competitive field of medical device manufacturing.
“Mdevice Co. Ltd. trades at a P/E of 22.6 (fair value) with strong ROE of 29.2%. 3Y revenue CAGR of 112.1% highlights clear growth momentum.”
Ask for details →Mdevice Co. Ltd. (ticker: 226590) is a company listed on KRX in the Technology sector (Electronic Components). Market cap is $242.2B.
The current price is ₩22,600 with a P/E ratio of 22.57x and P/B of 5.12x.
ROE is 29.15% and operating margin is 11.96%. Annual revenue is $96.5B.